Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Psychosom Med. 2015 Feb-Mar;77(2):167–175. doi: 10.1097/PSY.0000000000000143

Table 2.

First Clinically Significant Improvement by Week1

Week Active (n=200) Placebo (n=114)
n Percent Cumulative Percent n Percent Cumulative Percent
1 50 25.0 25.0 23 20.2 20.2
2 53 26.5 51.5 17 14.9 35.1
3 20 10.0 61.5 21 18.4 53.5
4 23 11.5 73.0 16 14.0 67.5
5 22 11.0 84.0 17 14.9 82.5
6 9 4.5 88.5 4 3.5 86.0
7 9 4.5 93.0 7 6.1 92.1
8 14 7.0 100.0 9 7.9 100.0
1

Participants who had clinically significant improvement (>=50% reduction in hot flash frequency) at any time in the 8-week study (n=314).